Clinical Trial Update: R-3750 in Patients With Mild to Moderate Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for R-3750 in adults with Ulcerative colitis is currently recruiting, sponsored by Rise Therapeutics LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• R-3750

Snippet

Sponsor: Rise Therapeutics LLC | Conditions: Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate | Phase 1 | Status: RECRUITING